Hypertension Diagnostics (HDII) Short Interest Ratio & Short Volume → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free HDII Stock Alerts $0.0002 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Hypertension Diagnostics Short Interest DataCurrent Short Volume9,700 sharesPrevious Short Volume59,700 sharesChange Vs. Previous Month-83.75%Dollar Volume Sold Short$60.14Short Interest Ratio / Days to Cover0.0Last Record DateAugust 15, 2022Outstanding Shares52,390,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume0 sharesAverage Trading Volume4,409 sharesToday's Volume Vs. Average0% Short Selling Hypertension Diagnostics ? Sign up to receive the latest short interest report for Hypertension Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHDII Short Interest Over TimeHDII Days to Cover Over TimeHDII Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Hypertension Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20229,700 shares $60.14 -83.8%N/A0 $0.01 7/31/202259,700 shares $301.49 No ChangeN/A0.1 $0.01 1/15/2022145,800 shares $1,312.20 No ChangeN/A0.1 $0.01 12/15/202126,500 shares $251.75 No ChangeN/A0 $0.01 10/29/202134,700 shares $624.60 +199.1%N/A0 $0.02 10/15/202111,600 shares $208.80 No ChangeN/A0 $0.02 Get the Latest News and Ratings for HDII and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hypertension Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 9/15/202117,800 shares $181.56 -52.7%N/A0 $0.01 8/31/202137,600 shares $481.28 +295.8%N/A0 $0.01 8/13/20219,500 shares $151.05 -5.0%N/A0 $0.02 7/30/202110,000 shares $174.00 No ChangeN/A0 $0.02 6/30/20218,500 shares $160.65 No ChangeN/A0 $0.02 4/30/202114,200 shares $269.80 No ChangeN/A0 $0.02 3/15/20211,000 shares $31.20 -83.9%N/A0 $0.03 2/26/20216,200 shares $290.78 No ChangeN/A0 $0.05 1/15/20216,800 shares $113.56 No ChangeN/A0 $0.02 12/31/20206,800 shares $133.28 No ChangeN/A0 $0.02 12/15/20206,800 shares $185.30 No ChangeN/A0 $0.03 11/15/20201,000 shares $33.40 No ChangeN/A0 $0.03 10/30/20201,000 shares $27.40 -97.1%N/A0 $0.03 10/15/202034,500 shares $1,017.75 +3,350.0%N/A0 $0.03 9/30/20201,000 shares $42.10 No ChangeN/A0 $0.04 9/15/20201,000 shares $77.90 -98.7%N/A0 $0.08 8/31/202078,000 shares $8,268.00 +20.4%N/A0 $0.11 8/14/202064,800 shares $7,614.00 -39.8%N/A0 $0.12 7/31/2020107,600 shares $10,749.24 +51.1%N/A0 $0.10 7/15/202071,200 shares $11,206.88 +931.9%N/A0 $0.16 6/30/20206,900 shares $717.60 -41.0%N/A0 $0.10 6/15/202011,700 shares $1,719.90 +7.3%N/A0 $0.15 5/29/202010,900 shares $1,276.39 -90.2%N/A0 $0.12 5/15/2020111,400 shares $4,132.94 +370.0%N/A0 $0.04 4/30/202023,700 shares $355.50 -1.3%N/A0 $0.02 4/15/202024,000 shares $420.00 +3,900.0%N/A0 $0.02 3/31/2020600 shares $10.80 No ChangeN/A0 $0.02 2/28/2020158,500 shares $2,678.65 No ChangeN/A0 $0.02 1/31/2020100 shares $0.97 No ChangeN/A0 $0.01 HDII Short Interest - Frequently Asked Questions What is Hypertension Diagnostics' current short interest? Short interest is the volume of Hypertension Diagnostics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 9,700 shares of HDII short. Learn More on Hypertension Diagnostics' current short interest. Is Hypertension Diagnostics' short interest increasing or decreasing? Hypertension Diagnostics saw a decrease in short interest during the month of August. As of August 15th, there was short interest totaling 9,700 shares, a decrease of 83.8% from the previous total of 59,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hypertension Diagnostics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Hypertension Diagnostics: RenovaCare, Inc. (0.00%), CVR Medical Corp. (0.03%), Bruush Oral Care Inc. (77.14%), Nyxoah S.A. (2.90%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.13 billion), Charter Communications, Inc. ($3.94 billion), Coinbase Global, Inc. ($2.38 billion), Lucid Group, Inc. ($2.30 billion), T. Rowe Price Group, Inc. ($2.22 billion), Williams-Sonoma, Inc. ($2.02 billion), Plug Power Inc. ($1.94 billion), Chesapeake Energy Co. ($1.91 billion), Unity Software Inc. ($1.82 billion), and Rivian Automotive, Inc. ($1.74 billion). View all of the most shorted stocks. What does it mean to sell short Hypertension Diagnostics stock? Short selling HDII is an investing strategy that aims to generate trading profit from Hypertension Diagnostics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hypertension Diagnostics? A short squeeze for Hypertension Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HDII, which in turn drives the price of the stock up even further. How often is Hypertension Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HDII, twice per month. The most recent reporting period available is August, 15 2022. More Short Interest Resources from MarketBeat Related Companies: RenovaCare Short Interest Data CVR Medical Short Interest Data Bruush Oral Care Short Interest Data Nyxoah Short Interest Data Oncologix Tech Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HDII) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold